GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.…
After a number of delays, the first Zofran birth defects bellwether trial is expected to begin in October 2021.…
The makers of Zofran argue that a recent FDA rejection of calls to investigate old data on whether it causes birth defects gives the company protection from hundreds of lawsuits.…
A new study links NDMA found in Zantac to a higher risk of gastrointestinal cancers than other heartburn drugs.…
A new study reports to have found how Zantac changes into NDMA, which has been linked to an increased risk of cancer.…
A Zantac lawsuit claims the recalled heartburn drug gave a man bladder cancer which required multiple surgeries and continuous medical monitoring.…
A massive class action lawsuit filed by hundreds of former Zantac users say the manufacturers engaged in organized crime-like activities and should be made to pay for cancer medical monitoring.…
A Zantac wrongful death lawsuit claims NDMA exposure resulted in a fatal case of cancer for a Louisiana man.…
Two Zantac manufacturers say they are under investigation by the Department of Justice for failing to inform them of the risks of NDMA in the recalled heartburn drug.…
A Zantac lawsuit claims the recalled heartburn drug caused a woman to develop uterine cancer and forced her to have a hysterectomy.…
